Brief Information of the Cell Line and Protein
Cell Line ID: CL000141 , LNCaP
Synonyms
LNCAP
LNCap
Ln-Cap
Lymph Node Carcinoma of the prostate
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0395
Protein ID: PT01584 , Steroid 17-alpha-hydroxylase/17,20 lyase
Gene Name CYP17A1
Organism Homo sapiens, Human
Protein Classification Enzyme
Uniprot ID P05093
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000141  Protein ID: PT01584
 
Compound ID Compound Name Compound Formula
CP0042010
(3S,10R,13S)-17-Imidazol-1-yl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C22H30N2O
 1
1
IC50 = 50 nM
   TI
   LI
   LO
   TS
CP0087810
[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate
   Show/Hide
C22H32O3
 1
1
IC50 = 56 nM
   TI
   LI
   LO
   TS
CP0183604
(10R,13S)-17-Imidazol-1-yl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C22H28N2O
 1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0845207
NRB 03731
   Show/Hide
C20H31N3O2
 1
1
IC50 = 178.2 nM
   TI
   LI
   LO
   TS
CP0465252
(3S,10R,13S,17R)-10,13-Dimethyl-17-pyrimidin-4-yl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C23H32N2O
 1
1
IC50 = 225 nM
   TI
   LI
   LO
   TS
CP0503397
(3S,10R,13S)-17-Benzoimidazol-1-yl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C26H32N2O
 1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
CP0955047
[(3R,10R,13S)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-(17E)-ylidene]-acetaldehyde oxime
   Show/Hide
C21H31NO2
 1
1
IC50 = 320 nM
   TI
   LI
   LO
   TS
CP0192333
(3S,10R,13S)-10,13-Dimethyl-17-[1,2,3]triazol-1-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C21H29N3O
 1
1
IC50 = 377.3 nM
   TI
   LI
   LO
   TS
CP0079026
(10R,13S)-10,13-Dimethyl-17-[1,2,3]triazol-1-yl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C21H27N3O
 1
1
IC50 = 386.9 nM
   TI
   LI
   LO
   TS
CP0919808
((3S,10R,13R)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-acetaldehyde oxime
   Show/Hide
C21H33NO2
 1
1
IC50 = 450 nM
   TI
   LI
   LO
   TS
CP0492333
(3S,10R,13S)-10,13-Dimethyl-17-pyrimidin-5-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C23H30N2O
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0534835
Acetic acid (10R,13S,17S)-10,13,17-trimethyl-2-methylene-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl ester
   Show/Hide
C23H32O3
 1
1
IC50 = 562 nM
   TI
   LI
   LO
   TS
CP0492241
(R)-4-((3S,10R)-3-Hydroxy-10-methyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-pentanoic acid bicyclo[3.2.1]oct-3-en-6-yl ester
   Show/Hide
C31H46O3
 1
1
IC50 = 616.5 nM
   TI
   LI
   LO
   TS
CP0921203
(3S,10R,13R)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,17-tetradecahydro-cyclopenta[a]phenanthren-16-one oxime
   Show/Hide
C19H29NO2
 1
1
IC50 = 628 nM
   TI
   LI
   LO
   TS
CP0492344
Acetic acid (10R,13S,17S)-10,13-dimethyl-3-oxo-8,9,10,11,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl ester
   Show/Hide
C21H26O3
 1
1
IC50 = 660.25 nM
   TI
   LI
   LO
   TS
CP0035494
(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol
   Show/Hide
C24H31NO
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0103591
(3S,10R,13S)-10,13-Dimethyl-17-[1,2,4]triazol-1-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C21H29N3O
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0392194
(10R,13S)-17-Benzoimidazol-1-yl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C26H30N2O
 1
1
IC50 = 915 nM
   TI
   LI
   LO
   TS
CP0454261
(10R,13S)-17-Isoxazol-5-yl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C22H27NO2
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0079769
(10R,13S)-10,13-Dimethyl-17-[1,2,4]triazol-1-yl-1,2,6,7,8,9,10,11,12,13,14,15-dodecahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C21H27N3O
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0414881
(3S,10R,13S)-17-Benzotriazol-1-yl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C25H31N3O
 1
1
IC50 = 1250 nM
   TI
   LI
   LO
   TS
CP0511900
(3S,10R,13S)-10,13-Dimethyl-17-tetrazol-2-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C20H28N4O
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0912044
(10R,13S)-17-{1-[(Z)-Hydroxyimino]-ethyl}-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13-decahydro-cyclopenta[a]phenanthren-3-one
   Show/Hide
C21H27NO2
 1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0476050
(3S,10R,13S)-10,13-Dimethyl-17-tetrazol-1-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C20H28N4O
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0376878
(3S,10R,13S)-10,13-Dimethyl-17-[1,2,3]triazol-2-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C21H29N3O
 1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0509786
(3S,10R,13S)-10,13-Dimethyl-17-pyrazin-2-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
   Show/Hide
C23H30N2O
 1
1
IC50 = 3810 nM
   TI
   LI
   LO
   TS
CP0925566
(3S,10R,13S)-17-Hydrazono-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,17-tetradecahydro-cyclopenta[a]phenanthren-16-one oxime
   Show/Hide
C19H29N3O2
 1
1
IC50 = 5900 nM
   TI
   LI
   LO
   TS
CP0853493
1-((3S,10R,13S,17R)-3,17-Dihydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-ethanone oxime
   Show/Hide
C21H33NO3
 1
1
IC50 = 12050 nM
   TI
   LI
   LO
   TS